ID Source | ID |
---|---|
PubMed CID | 5372405 |
CHEMBL ID | 1875667 |
CHEBI ID | 38864 |
SCHEMBL ID | 117991 |
MeSH ID | M0109853 |
Synonym |
---|
2-butenoic acid, 3-(((ethylamino)methoxyphosphinothioyl)oxy)-, 1-methylethyl ester, (e)- |
safrotin, analytical standard |
31218-83-4 |
propan-2-yl (2e)-3-{[(ethylamino)(methoxy)phosphorothioyl]oxy}but-2-enoate |
CHEBI:38864 , |
o-methyl o-{1-[(propan-2-yl)oxycarbonyl]prop-1-en-2-yl} ethylamidothiophosphate |
propetamphos |
1-methylethyl (e)-3-(((ethylamino)methoxyphosphinothioyl)oxy)-2-butenoate |
(e)-1-methylethyl 3-(((ethylamino)methoxyphosphinothioyl)oxy)-2-butenoate |
NCGC00163952-01 |
isopropyl (2e)-3-{[(ethylamino)(methoxy)phosphorothioyl]oxy}but-2-enoate |
NCGC00163952-02 |
propan-2-yl 3-[ethylamino(methoxy)phosphinothioyl]oxybut-2-enoate |
propetamphos (ban) |
D08437 |
seraphos |
propan-2-yl (e)-3-[ethylamino(methoxy)phosphinothioyl]oxybut-2-enoate |
NCGC00163952-03 |
C18669 |
cas-31218-83-4 |
tox21_300863 |
NCGC00254767-01 |
dtxsid7032470 , |
dtxcid5012470 |
2-butenoic acid, 3-(((ethylamino)methoxyphosphinothioyl)oxy)-, 1-methylethyl ester |
58995-37-2 |
2-butenoic acid, 3-(((ethylamino)methoxyphospinothioyl)oxy)-, 1-methylethyl ester |
ai3-27989 |
AKOS015960933 |
2-butenoic acid, 3-[[(ethylamino)methoxyphosphinothioyl]oxy]-, 1-methylethyl ester |
CHEMBL1875667 |
(+/-)-propetamphos |
propetamphos [mi] |
propetamphos [jan] |
propetamphos [hsdb] |
propetamphos [mart.] |
SCHEMBL117991 |
san 52139 |
sandoz 52139 |
2-butenoic acid, 3-(((ethylamino)methoxyphosphinothioyl)oxy)-, isopropyl ester, (e)- |
BZNDWPRGXNILMS-VQHVLOKHSA-N |
vel 4283 |
isopropyl (2e)-3-([(ethylamino)(methoxy)phosphorothioyl]oxy)-2-butenoate |
(e)-3-[[(ethylamino)methoxyphosphinothioyl]oxy]-2-butenoic acid 1-methyl-ethyl ester |
e-propetamphos |
2-butenoic acid, 3-[[(ethylamino)methoxyphosphinothioyl]oxy]-, 1-methylethyl ester, (e)- |
W-110796 |
trans-isopropyl-3-[[(ethylamino)methoxyfosfinothioyl]oxy]crotonate |
propetamphos, pestanal(r), analytical standard |
propetamphos 10 microg/ml in cyclohexane |
propetamphos 100 microg/ml in cyclohexane |
(e)-isopropyl 3-((ethylamino)(methoxy)phosphorothioyloxy)but-2-enoate |
isopropyl (e)-3-(((ethylamino)(methoxy)phosphorothioyl)oxy)but-2-enoate |
Q18629963 |
AKOS040744709 |
HY-119525 |
CS-0068655 |
Propetamphos is a new organophosphorous compound with broad spectrum acaricidal and insecticidal activity. It is mainly used for sheep dipping.
Excerpt | Reference | Relevance |
---|---|---|
"Propetamphos is a new organophosphorous compound with broad spectrum acaricidal and insecticidal activity. " | ( Control of sheep scab and other sheep ectoparasites with propetamphos. Bramley, PS; Henderson, D, 1984) | 1.96 |
"Propetamphos is a member of the vinyl phosphate group of insecticides and is mainly used for sheep dipping. " | ( Development of a urinary biomarker for exposure to the organophosphate propetamphos: data from an oral and dermal human volunteer study. Cocker, J; Garfitt, SJ; Jones, K; Mason, HJ, ) | 1.81 |
Excerpt | Reference | Relevance |
---|---|---|
"This study was aimed at determining the acute and chronic toxic effects of cypermethrin, propetamphos, and combined cypermethrin and propetamphos." | ( The acute and chronic toxic effect of cypermethrin, propetamphos, and their combinations in rats. Eraslan, G; Kanbur, M; Karabacak, M; Şahin, S; Siliğ, Y; Soyer Sarica, Z, 2016) | 0.91 |
Excerpt | Reference | Relevance |
---|---|---|
" Although metabolism of propetamphos has been previously investigated (2,3), there is no pharmacokinetic data available in the literature." | ( Pharmacokinetics of propetamphos following intravenous administration in the F344 rat. Burka, LT; Dauterman, WC; Dix, K, 1992) | 0.91 |
Cyromazine and Propetamphos are used to control blowfly strike in sheep. The length of protection might be dosage related.
Excerpt | Relevance | Reference |
---|---|---|
" Rats were dosed via an indwelling jugular cannula at a dose of 12 mg/kg (one-tenth the oral LD-50)." | ( Pharmacokinetics of propetamphos following intravenous administration in the F344 rat. Burka, LT; Dauterman, WC; Dix, K, 1992) | 0.61 |
" It was concluded that if organophosphate resistant blowfly were present, the length of protection might be dosage related and that blowfly strike in sheep was almost equally controlled by Cyromazine and Propetamphos." | ( Propetamphos: a comparison of three formulations in preventing blowfly strike in sheep. Gruss, B; Janse van Rensburg, BJ, 1988) | 1.91 |
" No individual showed a significant depression compared with their pre-exposure levels of erythrocyte acetyl cholinesterase or plasma cholinesterase activity for either dosing route." | ( Development of a urinary biomarker for exposure to the organophosphate propetamphos: data from an oral and dermal human volunteer study. Cocker, J; Garfitt, SJ; Jones, K; Mason, HJ, ) | 0.36 |
" Log dosage probit analysis of propetamphos dose-response regression lines produced a resistance ratio based on LC(50) in the most resistant strain of approximately 103-fold." | ( Propetamphos resistance in Rhipicephalus bursa (Acari, Ixodidae). Amouei, A; Asgarian, F; Boudaghi, B; Boujhmehrani, H; Enayati, AA; Hemingway, J; Piazak, N; Sharif, M; Vahedi, N, 2009) | 2.08 |
Role | Description |
---|---|
EC 3.1.1.7 (acetylcholinesterase) inhibitor | An EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of enzyme acetylcholinesterase (EC 3.1.1.7), which helps breaking down of acetylcholine into choline and acetic acid. |
agrochemical | An agrochemical is a substance that is used in agriculture or horticulture. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Class | Description |
---|---|
phosphoramidate ester | A phosphoric ester (phosphate) that has an NR2 instead of an OH group. |
organophosphate insecticide | |
isopropyl ester | Any carboxylic ester resulting from the formal condensation of a carboxylic acid with the hydroxy group of propan-2-ol. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
acetylcholinesterase | Homo sapiens (human) | Potency | 63.2609 | 0.0025 | 41.7960 | 15,848.9004 | AID1347395 |
pregnane X receptor | Rattus norvegicus (Norway rat) | Potency | 63.0957 | 0.0251 | 27.9203 | 501.1870 | AID651751 |
SMAD family member 2 | Homo sapiens (human) | Potency | 17.3739 | 0.1737 | 34.3047 | 61.8120 | AID1346924 |
SMAD family member 3 | Homo sapiens (human) | Potency | 17.3739 | 0.1737 | 34.3047 | 61.8120 | AID1346924 |
GLI family zinc finger 3 | Homo sapiens (human) | Potency | 25.7785 | 0.0007 | 14.5928 | 83.7951 | AID1259392 |
AR protein | Homo sapiens (human) | Potency | 36.7195 | 0.0002 | 21.2231 | 8,912.5098 | AID743063 |
nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 13.7115 | 0.0010 | 22.6508 | 76.6163 | AID1224838; AID1224839; AID1224893 |
progesterone receptor | Homo sapiens (human) | Potency | 30.6379 | 0.0004 | 17.9460 | 75.1148 | AID1346795 |
retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 61.1306 | 0.0030 | 41.6115 | 22,387.1992 | AID1159552 |
estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 54.4827 | 0.0015 | 30.6073 | 15,848.9004 | AID1224849 |
farnesoid X nuclear receptor | Homo sapiens (human) | Potency | 0.0028 | 0.3758 | 27.4851 | 61.6524 | AID588527 |
pregnane X nuclear receptor | Homo sapiens (human) | Potency | 20.6557 | 0.0054 | 28.0263 | 1,258.9301 | AID1346982; AID720659 |
estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 2.1872 | 0.0002 | 29.3054 | 16,493.5996 | AID743075 |
aryl hydrocarbon receptor | Homo sapiens (human) | Potency | 20.8901 | 0.0007 | 23.0674 | 1,258.9301 | AID651777; AID743085; AID743122 |
thyroid hormone receptor beta isoform a | Homo sapiens (human) | Potency | 3.9811 | 0.0100 | 39.5371 | 1,122.0200 | AID588547 |
histone deacetylase 9 isoform 3 | Homo sapiens (human) | Potency | 61.1306 | 0.0376 | 17.0823 | 61.1927 | AID1259364 |
nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 61.1306 | 0.0006 | 27.2152 | 1,122.0200 | AID651741 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 9 (27.27) | 18.7374 |
1990's | 10 (30.30) | 18.2507 |
2000's | 8 (24.24) | 29.6817 |
2010's | 4 (12.12) | 24.3611 |
2020's | 2 (6.06) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (26.48) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (2.94%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 33 (97.06%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |